Juan Ramón Alaix
CEO & Director
Glenn C. David
Executive VP & CFO
Executive VP and President of Global Manufacturing & Supply
Catherine A. Knupp
Executive VP and President of Research & Development
Clinton A. Lewis Jr.
EVP and President of International Ops., Commercial Development, Global Genetics & Aquatic Health
Kristin C. Peck
Executive VP and Group President of U.S. Operations, Business Development & Strategy
Zoetis was founded in the year 1952. The company has been operational for almost over 66 years now. The company was founded on the basis of doing research on many drugs by Pfizer, that included Oxytetracycline. Therefore a 732-acre land was purchased, and a development facility was established as well, in Terra Haute, Indiana. The former name of the company was Vigo, which was later changed to Pfizer Animal Health in 1988. Then in the year 1995, due to the acquisition of the Norden Laboratories from Glaxo Smith Kline - it boosted the animal care division of Pfizer.
A secondary research centre was also opened in the year 2003, and during the years from 2007 till 2011, the company had acquired various healthcare companies that will benefit Pfizer's range of products in multiple countries worldwide. The name of the company was again changed to the current company name, in the year 2012. By the year 2012, the revenues of the company reached $4.34 billion. In the year 2012, the company had become a public limited company. In the year 2015, the company had acquired Pharmaq for about $765 million. Also, as of the year 2018, Abaxis was also purchased for about $1.9 billion. The headquarters of the company is based in 10 Sylvan Way. The name of the place is Parsippany, while the name of the state is New Jersey, USA. The area pin code is 07054.
Zoetis is a company based in America that focuses on developing, discovering and also manufacturing of various kinds of drugs and medicines, vaccines and other diagnostic products for animal care. The current CEO of the company is Juan Ramon Alaix. As of the year 2017, the total revenue generated by the company is more than $5,300 million. Also, the number of employees working at the company, as of 2017, is more than 9,200.
The primary services provided by the company include allowing customers and clients to obtain various kinds of medicines, vaccines and other diagnostic products for animal, including domestic pets too. The company is also the most significant drug maker for animals in the world. It also produces medical products and drugs for fishes as well.
Please log in again. The login page will open in a new window. After logging in you can close it and return to this page.